More mechanistic insights, but translational progress is slow.

The author discusses studies related to glomerular biology and disease that were released in 2012. He describes one study that investigated levels of anti-PLA2R antibodies in patients with idiopathic membranous nephropathy and nephrotic-range proteinuria. He mentions another study that tested novel treatment approaches in type 2 diabetic nephropathy. He believes that a gap still exists between people's understanding of disease mechanisms and their ability to devise effective therapy.